ARROWHEAD PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$10.6M, a 1505% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$11.4M, a 664% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was -$11.4M, a 664% decline from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.49M, a 126% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $5.8M, a 29.2% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$11.4M -$10.6M -$9.94M -1505% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-26
Q2 2024 -$1.45M $2.16M +$2.84M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$4.29M -$805K -$316K -64.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$3.97M -$2.14M -$2.48M -731% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q3 2023 -$1.49M -$660K -$2.33M -139% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-26
Q2 2023 $844K -$680K -$1.54M -179% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.39M -$489K -$3.3M -117% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $5.69M $340K -$109K -24.3% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q3 2022 $5.8M $1.67M +$163K +10.8% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-26
Q2 2022 $5.64M $863K -$1.08M -55.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $6.72M $2.81M +$1.4M +98.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $5.32M $449K -$2.87M -86.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-06
Q3 2021 $8.19M $1.51M -$179K -10.6% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-29
Q2 2021 $8.37M $1.94M -$391K -16.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $8.76M $1.41M -$990K -41.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $9.75M $3.32M +$1.14M +52.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q3 2020 $8.61M $1.69M -$552K -24.6% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-28
Q2 2020 $9.16M $2.34M +$595K +34.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.56M $2.4M +$518K +27.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $8.05M $2.18M +$1.09M +99.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $6.96M $2.24M +$1.83M +446% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-22
Q2 2019 $5.13M $1.74M +$1.43M +455% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $3.7M $1.89M +$1.74M +1160% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.96M $1.09M +$477K +77.6% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-05
Q3 2018 $1.49M $410K +$890K Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 $599K $314K +$119K +61.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $479K $150K +$62.7K +72% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $417K $614K -$2.2M -78.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $2.62M -$479K -$54.8K -12.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-11-25
Q2 2017 $2.67M $194K +$274K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $2.4M $87.1K -$362K -80.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $2.76M $2.82M +$2.74M +3564% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $22.1K -$424K -$914K -187% Jul 1, 2016 Sep 30, 2016 10-K 2018-12-11
Q2 2016 $936K -$79.3K -$137K -237% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $1.07M $449K -$500K -52.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $1.57M $76.9K -$2.46M -97% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-06
Q3 2015 $4.04M $489K +$560K Jul 1, 2015 Sep 30, 2015 10-K 2017-12-12
Q2 2015 $3.48M $57.7K -$1.02M -94.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $4.49M $949K +$3.72M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $773K $2.54M +$6.22M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 -$5.44M -$70.9K +$5.74M +98.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 -$11.2M $1.07M +$861K +406% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 -$12M -$2.77M -$1.22M -78.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$10.8M -$3.68M -$3.71M -12642% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 -$7.11M -$5.81M -$5.58M -2513% Jul 1, 2013 Sep 30, 2013 10-K 2015-12-14
Q2 2013 -$1.53M $212K +$1.65M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$3.18M -$1.55M -$835K -117% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q4 2012 -$2.34M $29.3K -$1.32M -97.8% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-04
Q3 2012 -$1.02M -$222K -$188K -556% Jul 1, 2012 Sep 30, 2012 10-K 2014-11-25
Q2 2012 -$833K -$1.44M -$1.26M -723% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $429K -$715K -$1.44M -199% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $1.87M $1.35M +$823K +155% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 $1.05M -$33.9K Jul 1, 2011 Sep 30, 2011 10-K 2012-12-28
Q2 2011 -$175K -$1.65M -112% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 $724K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $529K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q2 2010 $1.48M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.